PHOTO: JAN ENGWERDA
STRATEGY ▶▶▶
In the US the No Antibiotics Ever movement gains traction. As a re- sult mortality has risen by 2%.
When the draft for the European One Health Action Plan against Antimicrobial Resistance (AMR) was written, Ms Schreijer proposed an amendment in September that ensures the availability of agents against certain protozoa, such as coccidia. Ms Schreijer’s amendment was approved by the Eu- ropean Parliament and was incorporated in a resolution for the European Commission. Ms Schreijer thinks that the unnecessary limitation of coccid- iostats may even be counterproductive because broilers that receive no coccidiostats in their feed are ill more often. “It could unintentionally lead to a higher risk for humans of infection with dangerous bacteria such as salmonella and microbes from food,” she says. She emphasises that she val- ues preventing antibiotic resistance. “We carefully follow the debate on this subject. It is however more important to stim- ulate antibiotic reduction in the human sector before ban- ning feed additives and with that, increasing food safety risks by a surge in for example salmonella or by more
28 ▶ POULTRY WORLD | No. 2, 2019
dependence on third countries for, for example, chicken breast.” Ms Schreijer awaits a proposal for a revision of the EU-regulation for feed additives and if necessary, will take ac- tion if such a proposal limits the use of coccidiostats. At this moment, there are no clues that the European Com- mission plans to take coccidiostats off the list of feed addi- tives. There are parties pleading for this, such as the Federa- tion of Veterinarians of Europe (FVE). This organisation thinks that coccidiostats should no longer be classified as feed addi- tives. According to the FVE, it makes more sense to only allow the use of coccidiostats if the vet prescribes them as an anti- biotic. This could help to limit the resistance of Eimeria para- sites against certain types of coccidiostats. In a so-called position paper, the FVE also points out that ion- ophore coccidiostats may be used in human healthcare in the future, for the control of cancer. Some studies indicate that the anticoccidiosis agent monensin has an inhibiting effect on the spread of kidney cancer cells.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36
